Alerts will be sent to your verified email
Verify Email
NEPHROPLUS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Nephrocare Health Services is engaged in offering comprehensive dialysis care through its network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. Its widespread presence ensures patients have easy accessibility to dialysis services.
Nephrocare Health major competitors are Narayana Hrudayalay., Jupiter Life Line, RainbowChildrenS Med, Dr. Agarwal's Health, Dr. Lal Pathlabs, Metropolis Health., Vijaya Diagnostic.
Market Cap of Nephrocare Health is ₹6,608 Crs.
While the median market cap of its peers are ₹14,567 Crs.
Nephrocare Health seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Feb May | ||||||||||||||||||
| Investor Presentation | Feb May | ||||||||||||||||||
| Conference Call | Feb May | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
